- Release Date: 07/04/22 09:45
- Summary: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
- Price Sensitive: No
- Download Document 453.01KB
- Forums
- ASX - By Stock
- EMD
- Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMD (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.08M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.053 |
1 | 66492 | 0.051 |
2 | 130000 | 0.050 |
1 | 70000 | 0.046 |
1 | 100000 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 50000 | 1 |
0.055 | 106813 | 2 |
0.057 | 17500 | 1 |
0.058 | 29000 | 1 |
0.059 | 250000 | 1 |
Last trade - 10.02am 10/07/2024 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online